US 11851449
Heterocyclic amide compounds having an RORvt inhibitory action
granted A61PA61P1/04A61P17/06
Quick answer
US patent 11851449 (Heterocyclic amide compounds having an RORvt inhibitory action) held by Takeda Pharmaceutical Company Limited expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61P, A61P1/04, A61P17/06, A61P19/02, A61P25/00